Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Humanigen Inc (NQ: HGEN ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Humanigen Inc < Previous 1 2 3 4 5 6 7 8 9 Next > First Patient Dosed in Phase 2 Precision Medicine Study of Lenzilumab in Patients with Chronic Myelomonocytic Leukemia (CMML) October 26, 2021 From Humanigen, Inc. Via Business Wire European Commission Selects Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 October 25, 2021 From Humanigen, Inc. Via Business Wire Humanigen announces preparation of Phase 1b study of ifabotuzumab in solid tumors following presentation of Phase 1 study results at EANM‘21 October 22, 2021 From Humanigen, Inc. Via Business Wire Expert Ratings For Humanigen September 10, 2021 Over the past 3 months, 4 analysts have published their opinion on Humanigen (NASDAQ: Via Benzinga Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors October 20, 2021 From Humanigen, Inc. Via Business Wire Humanigen Announces Late-Breaking Presentation at the CHEST Annual Meeting Highlighting C-Reactive Protein as a Biomarker for Identifying Patients Most Likely to Benefit from treatment with Lenzilumab October 19, 2021 From Humanigen, Inc. Via Business Wire Humanigen’s Budget Impact Model Demonstrates Lenzilumab’s Potential Positive Economic Value in Hospitalized COVID-19 Patients October 11, 2021 From Humanigen, Inc. Via Business Wire The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs October 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Exposures Product Safety Humanigen Signs Contract With Clinigen for Lenzilumab Managed Access Program in Europe October 08, 2021 From Humanigen, Inc. Via Business Wire NASDAQ:HGEN Investor Notice: Investigation over Potential Securities Laws Violations by Humanigen, Inc. October 07, 2021 San Diego, CA -- (SBWIRE) -- 10/07/2021 -- An investigation was announced over potential securities laws violations by Humanigen, Inc. in connection with certain financial statements. Via SBWire Exposures COVID-19 Product Safety Humanigen Announces Participation and Presentation at Multiple Conferences in October October 04, 2021 From Humanigen, Inc. Via Business Wire Humanigen Submits All Planned Modules for Potential Conditional Marketing Authorization from the UK’s MHRA October 01, 2021 From Humanigen, Inc. Via Business Wire The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO October 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... Via Benzinga Exposures Product Safety Humanigen Announces Oral Presentation of Lenzilumab LIVE-AIR Phase 3 Study Results at IDWeek 2021 September 29, 2021 From Humanigen, Inc. Via Business Wire The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug September 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... Via Benzinga Exposures Product Safety Humanigen Announces the European Medicines Agency Has Appointed a Rapporteur and Co-rapporteur as Part of the Process Related to the Planned Submission of a Marketing Authorization Application (MAA) for Lenzilumab September 28, 2021 From Humanigen, Inc. Via Business Wire Humanigen Announces Participation and Presentation at Multiple Conferences in September September 14, 2021 From Humanigen, Inc. Via Business Wire The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout September 14, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... Via Benzinga Exposures COVID-19 60 Biggest Movers From Friday September 13, 2021 Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in... Via Benzinga The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs September 12, 2021 Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week. Humanigen, Inc. (NASDAQ: HGEN) was among the biggest... Via Benzinga Exposures COVID-19 Product Safety 12 Health Care Stocks Moving In Friday's After-Market Session September 10, 2021 Gainers Hepion Pharmaceuticals (NASDAQ:HEPA Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 10, 2021 Gainers IVERIC bio (NASDAQ:ISEE) shares increased by 63.11% to $14.18 during Friday's regular session. IVERIC bio's stock is trading at a volume of 120.3 million... Via Benzinga Why Humanigen Stock Is Sinking Today September 10, 2021 The Food and Drug Administration turned down Emergency Use Authorization of lenzilumab in treating hospitalized COVID-19 patients. Via The Motley Fool Exposures COVID-19 After FDA Rejection This Biopharma Stock Garners Analyst Downgrades, Price Cuts September 09, 2021 JPMorgan Via Benzinga Exposures Product Safety Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Gevo Shares Spike Higher September 09, 2021 Toward the end of trading Thursday, the Dow traded down 0.37% to 34,901.89 while the NASDAQ fell 0.03% to 15,281.73. The S&P also rose, gaining 0.31% to 4,499.94. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021 September 10, 2021 Upgrades According to JonesTrading, the prior rating for Orchid Island Capital Inc (NYSE: Via Benzinga Stocks Inch Higher as Dow Looks to Snap Skid September 09, 2021 The Dow Jones Industrial Index is up 68 points midday and on track to snap a three-day losing streak. Via Talk Markets Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Thursday's Intraday Session September 09, 2021 Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.1... Via Benzinga The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test September 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... Via Benzinga 48 Biggest Movers From Yesterday September 10, 2021 Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
